{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:42:50Z","timestamp":1760182970850,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.rdc.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T17:09:41Z","timestamp":1383239381000},"page":"855-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Developments in Large and Midsize Vasculitis"],"prefix":"10.1016","volume":"39","author":[{"given":"Maria Teresa","family":"Terreri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gleice","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2013.08.002_bib1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2005.046300","article-title":"EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides","volume":"65","author":"Ozen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.002_bib2","series-title":"Vasculitis","first-page":"67","article-title":"Pathogenesis of vasculitis","author":"Ball","year":"2008"},{"key":"10.1016\/j.rdc.2013.08.002_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2559.2009.03443.x","article-title":"The histological assessment of cutaneous vasculitis","volume":"56","author":"Carlson","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.rdc.2013.08.002_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2012.09.001","article-title":"Serum levels of alpha-smooth muscle actin and c-Met as biomarkers of the degree of severity of Henoch-Schonlein purpura nephritis","volume":"161","author":"Zang","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.rdc.2013.08.002_bib5","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/0002-9149(82)90256-9","article-title":"Fate of coronary aneurisms in Kawasaki disease: serial coronary angiography and long-term follow-up study","volume":"49","author":"Kato","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rdc.2013.08.002_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-009-1230-x","article-title":"Pathogenesis of Henoch-Sch\u00f6nlein purpura nephritis","volume":"25","author":"Lau","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.rdc.2013.08.002_bib7","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","article-title":"Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"22","author":"Lau","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.rdc.2013.08.002_bib8","first-page":"196","article-title":"Childhood vasculitides in Turkey: a nationwide survey","volume":"26","author":"Ozen","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.002_bib9","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00467-009-1336-1","article-title":"Medium-sized-vessel vasculitis","volume":"25","author":"Dillon","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.rdc.2013.08.002_bib10","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.38024","article-title":"Systemic polyarteritis nodosa in the young: a single centre experience over 32 years","volume":"65","author":"Eleftheriou","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.002_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpeds.2004.06.046","article-title":"Juvenile polyarteritis: results of a multicenter survey of 110 children","volume":"145","author":"Ozen","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2013.08.002_bib12","series-title":"Textbook of pediatric rheumatology","first-page":"470","article-title":"Vasculitis and its classification","author":"Cassidy","year":"2011"},{"key":"10.1016\/j.rdc.2013.08.002_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody\u2013associated small-vessel vasculitis","volume":"8","author":"Jennette","year":"2013","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"10.1016\/j.rdc.2013.08.002_bib14","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.24876","article-title":"Classification, presentation, and initial treatment of Wegener\u2019s granulomatosis in childhood","volume":"60","author":"Cabral","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.002_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semarthrit.2008.05.004","article-title":"Churg-Strauss syndrome in childhood: a systematic review and clinical comparison with adult patients","volume":"39","author":"Zwerina","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.002_bib16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1681\/ASN.V1271493","article-title":"Antineutrophil cytoplasmic autoantibody\u2013associated glomerulonephritis in children","volume":"12","author":"Hattori","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2013.08.002_bib17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1529-0131(199809)41:9<1538::AID-ART3>3.0.CO;2-M","article-title":"The immunopathogenesis and management of Kawasaki syndrome","volume":"41","author":"Leung","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2013.08.002_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/BOR.0b013e32833cf051","article-title":"Kawasaki disease: update on pathogenesis","volume":"22","author":"Yeung","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.08.002_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QCO.0b013e3282fbf9cd","article-title":"Kawasaki disease: an overview","volume":"21","author":"Pinna","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.rdc.2013.08.002_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2009.12.004","article-title":"Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin","volume":"9","author":"Galeotti","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.rdc.2013.08.002_bib21","first-page":"598","article-title":"Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: BCG scar changes in Kawasaki's disease","volume":"29","author":"Hulme","year":"2012","journal-title":"Emerg Med J"},{"key":"10.1016\/j.rdc.2013.08.002_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1699-0463.1992.tb00870.x","article-title":"Antibodies against neutrophil cytoplasmic components in Kawasaki disease","volume":"100","author":"Soppi","year":"1992","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.rdc.2013.08.002_bib23","first-page":"1141","article-title":"Kawasaki disease: summary of the American Heart Association Guidelines","volume":"74","author":"Freeman","year":"2006","journal-title":"Am Fam Physician"},{"issue":"7","key":"10.1016\/j.rdc.2013.08.002_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00246-012-0232-9","article-title":"Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of 2004 American Heart Association Guidelines","volume":"33","author":"Guelani","year":"2012","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"10.1016\/j.rdc.2013.08.002_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/157489008784705359","article-title":"Effect of immunoglobulin therapy on blood viscosity and potential concerns of thromboembolism, especially in patients with acute Kawasaki disease","volume":"3","author":"Baba","year":"2008","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"issue":"2","key":"10.1016\/j.rdc.2013.08.002_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1067\/mpd.2000.109025","article-title":"Kawasaki disease: who is at risk?","volume":"137","author":"Newburger","year":"2000","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.rdc.2013.08.002_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/eri.09.109","article-title":"Pathogenesis and management of Kawasaki disease","volume":"8","author":"Rowley","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.rdc.2013.08.002_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/INF.0b013e3181f386db","article-title":"External validation of a risk score to predict intravenous immunoglobulin resistance in patients with Kawasaki disease","volume":"30","author":"Seki","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.rdc.2013.08.002_bib29","first-page":"803","article-title":"Corticosteroid treatment of refractory Kawasaki disease","volume":"33","author":"Lang","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.002_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/S0022-3476(03)00387-1","article-title":"Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children","volume":"143","author":"Okada","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2013.08.002_bib31","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2013.08.002_bib32","first-page":"15","article-title":"The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy","volume":"53","author":"Ogata","year":"2009","journal-title":"J\u00a0Cardiol"},{"issue":"8","key":"10.1016\/j.rdc.2013.08.002_bib33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/11631440-000000000-00000","article-title":"Epidemiology and management of Kawasaki disease","volume":"72","author":"Luca","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.rdc.2013.08.002_bib34","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous gammaglobulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2013.08.002_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome","volume":"146","author":"Burns","year":"2005","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.rdc.2013.08.002_bib36","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpeds.2010.06.014","article-title":"Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease","volume":"157","author":"Choueiter","year":"2010","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.rdc.2013.08.002_bib37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2013.08.002_bib38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpeds.2010.10.012","article-title":"Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study","volume":"158","author":"Son","year":"2011","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.rdc.2013.08.002_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3899\/jrheum.110877","article-title":"Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series","volume":"39","author":"Mori","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2013.08.002_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jpeds.2012.01.018","article-title":"Resistant Kawasaki disease treated with anti-CD20","volume":"160","author":"Sauvaget","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.rdc.2013.08.002_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/MBC.0b013e32833d6ec2","article-title":"Management of myocardial infarction in children with Kawasaki disease","volume":"21","author":"Paredes","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rdc.2013.08.002_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1442-200X.2004.01840.x","article-title":"Use of laboratory data to identify risk factors of giant coronary aneurisms due to Kawasaki disease","volume":"46","author":"Nakamura","year":"2004","journal-title":"Pediatr Int"},{"issue":"8","key":"10.1016\/j.rdc.2013.08.002_bib43","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00246-011-9986-8","article-title":"Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide","volume":"32","author":"Kaneko","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"10.1016\/j.rdc.2013.08.002_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1272\/jnms.76.124","article-title":"Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis?","volume":"76","author":"Fukazawa","year":"2009","journal-title":"J\u00a0Nippon Med Sch"},{"key":"10.1016\/j.rdc.2013.08.002_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pcl.2005.01.006","article-title":"Vasculitis in children","volume":"52","author":"Dedeoglu","year":"2005","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.rdc.2013.08.002_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.bor.0000197998.50450.f6","article-title":"Kawasaki disease","volume":"18","author":"Falcini","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.08.002_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0104-4230(11)70062-8","article-title":"Prospective study of Kawasaki disease complications: review of 115 cases","volume":"57","author":"Alves","year":"2011","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.rdc.2013.08.002_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01744556","article-title":"Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis","volume":"7","author":"Kasuya","year":"1992","journal-title":"Heart Vessels Suppl"},{"issue":"6","key":"10.1016\/j.rdc.2013.08.002_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0049-0172(05)80028-9","article-title":"Heat shock (stress) proteins and autoimmunity in rheumatic diseases","volume":"22","author":"Schultz","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.002_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2249.2004.02644.x","article-title":"Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis","volume":"138","author":"Chauhan","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2013.08.002_bib51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI117029","article-title":"Perforin-secreting killer cell infiltration and expression of a 65-kd heat-shock protein in aortic tissue of patients with Takayasu's arteritis","volume":"93","author":"Seko","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2013.08.002_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/096721090000800210","article-title":"Immunophenotypic analysis of the aortic wall in Takayasu\u2019s arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions","volume":"8","author":"Inder","year":"2000","journal-title":"Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.rdc.2013.08.002_bib53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jvs.2010.06.173","article-title":"Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis","volume":"53","author":"Wang","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.rdc.2013.08.002_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/ard.2011.153007","article-title":"Takayasu arteritis is characterized by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab","volume":"71","author":"Hoyer","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2013.08.002_bib55","first-page":"506","article-title":"Pathogenesis of Takayasu's arteritis","volume":"14","author":"Noris","year":"2001","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.rdc.2013.08.002_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1536\/jhj.41.15","article-title":"Takayasu arteritis: insights into immunopathology","volume":"411","author":"Seko","year":"2000","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.rdc.2013.08.002_bib57","first-page":"913","article-title":"Takayasu arteritis in children","volume":"35","author":"Cakar","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.002_bib58","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2013.08.002_bib59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.tvir.2003.10.002","article-title":"Takayasu\u2019s arteritis in children","volume":"6","author":"Stanley","year":"2003","journal-title":"Tech Vasc Interv Radiol"},{"issue":"Suppl","key":"10.1016\/j.rdc.2013.08.002_bib60","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0167-5273(96)88780-8","article-title":"Current status of Takayasu arteritis in India","volume":"54","author":"Jain","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.rdc.2013.08.002_bib61","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/000331978503600606","article-title":"Spectrum of renovascular hypertension in the young in North India: A hospital based study on occurrence and clinical features","volume":"36","author":"Sharma","year":"1985","journal-title":"Angiology"},{"key":"10.1016\/j.rdc.2013.08.002_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1542\/peds.62.2.209","article-title":"Takayasu arteritis and renovascular hypertension in children","volume":"62","author":"Wiggelinkuizen","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2013.08.002_bib63","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s004670050526","article-title":"A\u00a0review of Takayasu arteritis in children in Gauteng, South Africa","volume":"12","author":"Hahn","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.rdc.2013.08.002_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01744551","article-title":"Takayasu arteritis in Korean children: clinical report of seventy cases","volume":"7","author":"Hong","year":"1992","journal-title":"Heart Vessels"},{"issue":"6","key":"10.1016\/j.rdc.2013.08.002_bib65","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00467-009-1312-9","article-title":"Large vessel vasculitis","volume":"25","author":"Gulati","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.rdc.2013.08.002_bib66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0002-8703(77)80178-6","article-title":"Takayasu's arteritis. Clinical study of 107 cases","volume":"93","author":"Lupi-Herrera","year":"1977","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.rdc.2013.08.002_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e3181cba0a3","article-title":"Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African and black patients","volume":"89","author":"Arnaud","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.rdc.2013.08.002_bib68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.RHU.0000073436.33243.2c","article-title":"Hypertension and elevated ESR as diagnostic features of Takayasu arteritis in children","volume":"9","author":"Fieldston","year":"2003","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.002_bib69","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jvs.2009.09.038","article-title":"Circulation levels of acute phase proteins patients with Takayasu arteritis","volume":"51","author":"Ma","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.rdc.2013.08.002_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/01.CIR.100.1.55","article-title":"Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?","volume":"100","author":"Noris","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.08.002_bib71","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/rheumatology\/kei266","article-title":"Serum citokyne profiles and their correlations with disease activity in Takayasu\u2019s arteritis","volume":"45","author":"Park","year":"2006","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.rdc.2013.08.002_bib72","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcmg.2012.01.013","article-title":"Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences","volume":"5","author":"Tesuka","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.rdc.2013.08.002_bib73","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/art.20922","article-title":"Takayasu\u2019s arteritis: a study of 104 Italian patients","volume":"53","author":"Vanoli","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.rdc.2013.08.002_bib74","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/S0167-5273(96)02813-6","article-title":"Angiographic findings of Takayasu arteritis: new classification","volume":"54","author":"Hata","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.rdc.2013.08.002_bib75","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu\u2019s arteritis: Ankara 2008. Part II: final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.002_bib76","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.002_bib77","first-page":"1793","article-title":"Role of immunosuppressive therapy on clinical, immunological and angiografic outcome in active Takayasu\u2019s arteritis","volume":"30","author":"Valsakumar","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.002_bib78","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10067-007-0596-z","article-title":"Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis","volume":"26","author":"Shinjo","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.002_bib79","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jpeds.2008.04.049","article-title":"Treatment of Takayasu\u2019s arteritis with tumor necrosis factor antagonists","volume":"153","author":"Filocamo","year":"2008","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.rdc.2013.08.002_bib80","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","article-title":"Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis","volume":"50","author":"Hoffman","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2013.08.002_bib81","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ker380","article-title":"Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study","volume":"51","author":"Mekinian","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.08.002_bib82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/annrheumdis-2012-eular.2810","article-title":"Infliximab vs cyclosphosphamide in pediatric Takayasu's arteritis","volume":"71","author":"Stern","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2013.08.002_bib83","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/art.23373","article-title":"Successful treatment of a patient with Takayasu\u2019s arteritis using a humanized anti-interleukin 6 receptor antibody","volume":"58","author":"Nishimoto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.002_bib84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8028-z","article-title":"Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?","volume":"34","author":"Galarza","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2013.08.002_bib85","first-page":"393","article-title":"Surgical management of Takayasu\u2019s arteritis in children and adolescents","volume":"18","author":"Reddy","year":"2007","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.rdc.2013.08.002_bib86","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/03009740510026526","article-title":"Clinical characteristics and outcomes of Takayasu\u2019s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment and angiographic classification","volume":"34","author":"Park","year":"2005","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2013.08.002_bib87","first-page":"1081","article-title":"Takayasu's arteritis in children","volume":"18","author":"Morales","year":"1991","journal-title":"J\u00a0Rheumatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:37Z","timestamp":1760181217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0889857X13000756"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.08.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developments in Large and Midsize Vasculitis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}